1. Home
  2. Bills
  3. H.R. 1193

H.R. 1193 · 117th Congress · 2021–2022

Cardiovascular Advances in Research and Opportunities Legacy Act

H.R. 1193 in the 117th Congress (2021–2022) became law — introduced on Feb 22, 2021, sponsored by Andy Barr with 183 co-sponsors.

During the 117th Congress (2021–2022), Joe Biden was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Became law
Introduced
Feb 22, 2021
Co-sponsors
183
Policy area
Health
Public law
Public Law 117-244

What it does

Cardiovascular Advances in Research and Opportunities Legacy Act This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Andy Barr (R-KY). Co-sponsors: 70 Democrats, 113 Republicans.

Where it stands

  • IntroducedFeb 22, 2021
  • Passed the HouseDec 8, 2021
  • Passed the SenateDec 1, 2022
  • Sent to the PresidentDec 16, 2022
  • Became lawDec 20, 2022

Latest action: Became Public Law No: 117-244. (Dec 20, 2022)

Other Health bills in the 117th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 1193 (117th Congress): Cardiovascular Advances in Research and…,” https://www.capitolreceipts.com/bill/117-hr-1193/cardiovascular-advances-in-research-and-opportunities-legacy-act (accessed 2026-10-17).

Open the interactive version ›